Tongling Jyair Bio-Tech Co., Ltd. Achieved RMB 310 Million Operating Revenue in the First Half of 2025

    Tongling Jieya Biotechnology Co., Ltd. (China) achieved operating revenue of approximately RMB 310 million in the first half of 2025, representing a year-on-year increase of 8.79%. Its net profit attributable to shareholders of the listed company reached around RMB 32.5837 million, with a year-on-year growth of 22.55%. The basic earnings per share (EPS) stood at RMB 0.40 per share, up 21.21% year-on-year.